Variants in BET1L and TNRC6B associate with increasing fibroid volume and fibroid type among European Americans

Human Genetics

Volumn 132, Issue 12, 2013, Pages 1361-1369

  Edwards, Todd L ^a,b   Hartmann, Katherine E ^a,b   Velez Edwards, Digna R ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKED EARLY IN TRANSPORT 1 HOMOLOG; CARRIER PROTEIN; TRANSCRIPTION FACTOR; TRINUCLEOTIDE REPEAT CONTAINING 6B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERUS MYOMA;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LEIOMYOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QC-SNARE PROTEINS; RNA-BINDING PROTEINS; TUMOR BURDEN; UNITED STATES; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84889252617     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-013-1340-1     Document Type: Article

References (45)

1. Baird DD, Dunson DB (2003) Why is parity protective for uterine fibroids? Epidemiology 14:247-250
2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100-107
3. Bonatz G, Frahm SO, Andreas S, Heidorn K, Jonat W, Parwaresch R (1998) Telomere shortening in uterine leiomyomas. Am J Obstet Gynecol 179:591-596
4. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH (2012) The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol 206:211-219
5. Cha PC, Takahashi A, Hosono N, Low SK, Kamatani N, Kubo M, Nakamura Y (2011) A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nat Genet 43:447-450
6. Cramer SF, Patel A (1990) The frequency of uterine leiomyomas. Am J Clin Pathol 94:435-438
7. Dragomir AD, Schroeder JC, Connolly A, Kupper LL, Hill MC, Olshan AF, Baird DD (2010) Potential risk factors associated with subtypes of uterine leiomyomata. Reprod Sci 17:1029-1035
8. Edwards, Michels K, artmann KE, Velez Edwards D (2013) Replication of fibroid GWAS associations in 10q24.33, 11p15.5, and 22q13.1 in a US population of reproductive aged women. Hum Genet (Epub ahead of print)
9. Eggert SL, Huyck KL, Somasundaram P, Kavalla R, Stewart EA, Lu AT, Painter JN, Montgomery GW, Medland SE, Nyholt DR, Treloar SA, Zondervan KT, Heath AC, Madden PA, Rose L, Buring JE, Ridker PM, Chasman DI, Martin NG, Cantor RM, Morton CC (2012) Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata. Am J Hum Genet 91:621-628
10. Eldar-Geva T, Meagher S, Healy DL, MacLachlan V, Breheny S, Wood C (1998) Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril 70:687-691
11. El-Gharib MN, Elsobky ES (2010) Cytogenetic aberrations and the development of uterine leiomyomata. J Obstet Gynaecol Res 36:101-107
12. Exacoustos C, Rosati P (1993) Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol 82:97-101
13. Faerstein E, Szklo M, Rosenshein NB (2001) Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 153:11-19
14. Flake GP, Andersen J, Dixon D (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111:1037-1054
15. Guo Y, Shen H, Xiao P, Xiong DH, Yang TL, Guo YF, Long JR, Recker RR, Deng HW (2006) Genome wide linkage scan for quantitative trait loci underlying variation in age at menarche. J Clin Endocrinol Metab 91:1009-1014
16. Hartmann KE, Birnbaum H, Ben-Hamadi R, Wu EQ, Farrell MH, Spalding J, Stang P (2006) Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 108:930-937
17. Kurbanova MK, Koroleva AG, Sergeev AS (1989) Genetic-epidemiologic analysis of uterine myoma: assessment of repeated risk. Genetika 25:1896-1898
18. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE (2009) Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol 113:630-635
19. Laughlin SK, Herring AH, Savitz DA, Olshan AF, Fielding JR, Hartmann KE, Baird DD (2010a) Pregnancy-related fibroid reduction. Fertil Steril 94:2421-2423
20. Laughlin SK, Schroeder JC, Baird DD (2010b) New directions in the epidemiology of uterine fibroids. Semin Reprod Med 28:204-217
21. Laughlin SK, Hartmann KE, Baird DD (2011) Postpartum factors and natural fibroid regression. Am J Obstet Gynecol 204:496
22. Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y (1996) Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol 103:909-914
23. Luoto R, Kaprio J, Rutanen EM, Taipale P, Perola M, Koskenvuo M (2000) Heritability and risk factors of uterine fibroids-the Finnish Twin Cohort study. Maturitas 37:15-26
24. Malik M, Norian J, McCarthy-Keith D, Britten J, Catherino WH (2010) Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med 28:169-179
25. Marsh EE, Lin Z, Yin P, Milad M, Chakravarti D, Bulun SE (2008) Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. Fertil Steril 89:1771-1776
26. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ (1997) Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90:967-973
27. Marshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri RL, Stampfer MJ, Hunter DJ (1998) A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70:432-439
28. Moore AB, Flake GP, Swartz CD, Heartwell G, Cousins D, Haseman JK, Kissling GE, Sidawy MK, Dixon D (2008) Association of race, age and body mass index with gross pathology of uterine fibroids. J Reprod Med 53:90-96
29. Myers SL, Baird DD, Olshan AF, Herring AH, Schroeder JC, Nylander-French LA, Hartmann KE (2012) Self-report versus ultrasound measurement of uterine fibroid status. J Womens Health (Larchmt) 21:285-293
30. Ojeda VJ (1979) The pathology of hysterectomy specimens. N Z Med J 89:169-171
31. Parazzini F, Negri E, La VC, Chatenoud L, Ricci E, Guarnerio P (1996) Reproductive factors and risk of uterine fibroids. Epidemiology 7:440-442
32. Promislow JH, Makarushka CM, Gorman JR, Howards PP, Savitz DA, Hartmann KE (2004) Recruitment for a community-based study of early pregnancy: the right from the start study. Paediatr Perinat Epidemiol 18:143-152
33. Pulley J, Clayton E, Bernard GR, Roden DM, Masys DR (2010) Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin Transl Sci 3:42-48
34. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575
35. Ramzy AM, Sattar M, Amin Y, Mansour RT, Serour GI, Aboulghar MA (1998) Uterine myomata and outcome of assisted reproduction. Hum Reprod 13:198-202
36. Rosati P, Bellati U, Exacoustos C, Angelozzi P, Mancuso S (1989) Uterine myoma in pregnancy: ultrasound study. Int J Gynaecol Obstet 28:109-117
37. Samadi AR, Lee NC, Flanders WD, Boring JR III, Parris EB (1996) Risk factors for self-reported uterine fibroids: a case-control study. Am J Public Health 86:858-862
38. Snieder H, MacGregor AJ, Spector TD (1998) Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 83:1875-1880
39. Sozen I, Arici A (2002) Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril 78:1-12
40. Takeda T, Sakata M, Isobe A, Miyake A, Nishimoto F, Ota Y, Kamiura S, Kimura T (2008) Relationship between metabolic syndrome and uterine leiomyomas: a case-control study. Gynecol Obstet Invest 66:14-17
41. Treloar SA, Martin NG, Dennerstein L, Raphael B, Heath AC (1992) Pathways to hysterectomy: insights from longitudinal twin research. Am J Obstet Gynecol 167:82-88
42. Vollenhoven B (1998) Introduction: the epidemiology of uterine leiomyomas. Baillieres Clin Obstet Gynaecol 12:169-176
43. Willer CJ, Li Y, Abecasis GR (2010) METAL: fast and efficient meta-analysis of genome wide association scans. Bioinformatics 26:2190-2191
44. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, Rosenberg L (2004) Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 159:113-123
45. Wise LA, Ruiz-Narvaez EA, Palmer JR, Cozier YC, Tandon A, Patterson N, Radin RG, Rosenberg L, Reich D (2012) African ancestry and genetic risk for uterine leiomyomata. Am J Epidemiol 176:1159-1168